AN12855 (Table 1), a recently developed diazaborine InhA inhibitor that binds to both the cofactor and substrate-binding unit of InhA, was effective in acute and chronic models of tuberculosis and was able to act upon INH-resistant M. tuberculosis strains [28]. Here, INHA is linked to tuberculosis.